Today, opioids are the go-to treatment for people with severe pain, and alternatives are needed.

Hear how scientists are investigating a different kind of approach to meet pain where it starts.

On the latest episode of Targeting the Tephist Diseases, a new podcast by Bloomberg Media Studios and Vertex Pharmaceuticals.

What does it take to truly disrupt an industry? How do you overcome the fear of failure?

When is it time to take a risk? Hi, I'm Bob Pippman, Chairman and CEO of I Heart Media,

and these are the kind of questions we explore on my podcast, Math and Magic,

Stories from the Frontiers of Marketing. This season, I sit down with some of the most unique

thinkers to swap lessons and stories on making our work bigger and better. We'll hear from business

leaders like Steve Cooper, CEO of Warner Music Group. Technology is like an avalanche. You either

get out in front of it or it's just going to bury you. Listen to Math and Magic on our very own free

iHeartRadio app, Apple Podcast, or wherever you get your podcast.

This is Masters in Business with Barry Redholz on Bloomberg Radio.

This week on the podcast, I have an extra special guest, Tina Vandersteel. She heads the entire

emerging country debt team over at GMO, located in Boston, the venerable investing firm.

That's head by Jeremy Granthram. He's the GMO. Myself and Vandersteel talk about everything from

the risks involved in EM investing, how you can hedge, whether or not you should be investing

in the local currency or in dollar-denominated in debt. This is really a deep dive into a fascinating

and under-followed sector of the marketplace. It's trillions and trillions of dollars.

And yet, most of us are fairly unfamiliar with what goes on in EM. And really, Tina gives us a

masterclass in what you should be looking for and how you should be thinking about

the risks and potential rewards in EM. I really enjoyed the conversation. And I think you will

also. So with no further ado, my interview with GMO's Tina Vandersteel.

...